Answers are grounded in this paper and cite their sources.
Seventeen renal transplant recipients were studied prospectively from May 1971 to September 1972 for evidence of infection with herpes simplex virus (HSV), varicellazoster virus (VZ), or cytomegalovirus (CMV). Viruses were cultured from five patients. A 4-fold or greater increase in complement fixation (CF) antibodies was demonstrated for CMV in 10 patients, for HSV in 9 patients, and for VZ in 6 patients. These increases occurred usually 2 months after transplantation. CMV seroconversion occurred in all eight patients with a pretransplantation CMV CF antibody titer $1:4; only two of nine patients with no detectable pretransplantation titer subsequently developed CMV CF antibodies. Nine of 12 patients with a HSV pretransplantation titer $1:4; developed 4-fold or greater increases of HSV but none of five patients with no detectable pretransplantation HSV antibodies. No direct correlation could be made between the magnitude of VZ pretransplantation antibody titers and subsequent VZ seroconversions. Viral cultures were negative in the living related donors and in samples from 92 units of leukocyte-poor blood given to the renal recipient patients. The risk of viral infection did not appear to be correlated with the number of blood transfusions that a patient received or with his dosage of immunosuppressive therapy. Six patients with herpesvirus seroconversions developed increases in cold agglutinin titers at the same time. No statistical correlation could be made between the incidence of renal allograft rejection and the development of viral seroconversions or the appearance of cold agglutinins.
No takes yet. Share an insight, caveat, or question.
Pien et al. (1973) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: